Table of Contents
Liposome Drug Products: Bioavailability and Bioequivalence Issues
Bioavailability
Bioequivalence
Bioavailability/Bioequivalence
Types of Evidence to Establish BA/BE
Prerequisites for Using PK Method to Assess BA/BE
Classification of Liposome Drug Products Based on MPS
MPS Uptake Liposomes
MPS Avoidance Liposomes
The Key Issues
MPS Uptake: Suggested Scheme for BA/BE Determination
MPS Avoidance: Suggested Scheme for BA/BE Determination
Combined Scheme for Determination of BA/BE
Acknowledgements
|